Li Du

Area of research

Molecular Biology · Oncology

Research interest

Research interests include Ubiquitin and proteasome pathways, Peptidase Inhibition and Analysis, HIV/AIDS drug development and treatment, and HIV Research and Treatment.

h-index

citations

1,300

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Levo-tetrahydropalmatine inhibits the acquisition of ketamine-induced conditioned place preference by regulating the expression of ERK and CREB phosphorylation in rats

Behavioural Brain Research 2016cited by 32position: middledoi

Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease

Proceedings of the National Academy of Sciences 2013cited by 66position: firstdoi

Regulation of Adipose Differentiation by Fructose and GluT5

Molecular Endocrinology 2012cited by 70position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Anthony P. Heaney · University of California, Los Angeles2 papers (2012–2013)Jie Cao · Indiana University School of Medicine1 papers (2016–2016)Yongming Feng · Shanxi Medical University1 papers (2016–2016)Christian Hölscher · Shanxi Medical University1 papers (2016–2016)Leili Mirsadraei · Winthrop-University Hospital1 papers (2013–2013)Ronald M. Evans · Salk Institute for Biological Studies1 papers (2013–2013)Michael Downes · Salk Institute for Biological Studies1 papers (2013–2013)Yan Du · Xuzhou Medical College1 papers (2016–2016)Yujin Wang · Shanxi Medical University1 papers (2016–2016)Keming Yun · Shanxi Medical University1 papers (2016–2016)Marvin Bergsneider · UCLA Health1 papers (2013–2013)William H. Yong · University of California, Irvine1 papers (2013–2013)Johan W. Jonker · University Medical Center Groningen1 papers (2013–2013)Steven H. Young · Digestive Care (United States)1 papers (2013–2013)Hongliang Su · Shanxi Medical University1 papers (2016–2016)